Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Rachael L. Brake, Robyn Fabrey, Jeff Szwaya, Michael Fitzgerald, Natasha Iartchouk, Xin Guo, Keisuke Kuida, Fabian Zohren, and Mark Manfredi | ||||||||||||
Title | Abstract C176: The combination of mTORC1/2 and PI3K? inhibition alleviates PI3K pathway reactivation and leads to significant antitumor activity in multiple preclinical xenograft models. | ||||||||||||
|
|||||||||||||
URL | http://mct.aacrjournals.org/content/12/11_Supplement/C176.short | ||||||||||||
Abstract Text | Mol Cancer Ther November 2013 12:C176; doi:10.1158/1535-7163.TARG-13-C176 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|